GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » 4Front Ventures Corp (XCNQ:FFNT) » Definitions » Cyclically Adjusted PS Ratio

4Front Ventures (XCNQ:FFNT) Cyclically Adjusted PS Ratio : 0.02 (As of May. 29, 2025)


View and export this data going back to 2006. Start your Free Trial

What is 4Front Ventures Cyclically Adjusted PS Ratio?

As of today (2025-05-29), 4Front Ventures's current share price is C$0.005. 4Front Ventures's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was C$0.22. 4Front Ventures's Cyclically Adjusted PS Ratio for today is 0.02.

The historical rank and industry rank for 4Front Ventures's Cyclically Adjusted PS Ratio or its related term are showing as below:

XCNQ:FFNT' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.02   Med: 2.3   Max: 10.7
Current: 0.02

During the past years, 4Front Ventures's highest Cyclically Adjusted PS Ratio was 10.70. The lowest was 0.02. And the median was 2.30.

XCNQ:FFNT's Cyclically Adjusted PS Ratio is ranked better than
99.32% of 737 companies
in the Drug Manufacturers industry
Industry Median: 2.12 vs XCNQ:FFNT: 0.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

4Front Ventures's adjusted revenue per share data for the three months ended in Sep. 2024 was C$0.025. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is C$0.22 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


4Front Ventures Cyclically Adjusted PS Ratio Historical Data

The historical data trend for 4Front Ventures's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4Front Ventures Cyclically Adjusted PS Ratio Chart

4Front Ventures Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.49 5.89 5.93 1.36 0.56

4Front Ventures Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.47 0.56 0.65 0.48 0.29

Competitive Comparison of 4Front Ventures's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, 4Front Ventures's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4Front Ventures's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 4Front Ventures's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where 4Front Ventures's Cyclically Adjusted PS Ratio falls into.


;
;

4Front Ventures Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

4Front Ventures's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.005/0.22
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4Front Ventures's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, 4Front Ventures's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.025/133.0289*133.0289
=0.025

Current CPI (Sep. 2024) = 133.0289.

4Front Ventures Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201410 0.000 100.176 0.000
201501 0.000 98.604 0.000
201504 0.000 99.824 0.000
201507 0.000 100.691 0.000
201510 0.000 100.346 0.000
201601 0.000 99.957 0.000
201604 0.000 100.947 0.000
201607 0.000 101.524 0.000
201610 0.000 101.988 0.000
201701 0.000 102.456 0.000
201704 0.000 103.167 0.000
201707 0.253 103.278 0.326
201710 0.000 104.070 0.000
201801 0.000 104.578 0.000
201804 0.034 105.708 0.043
201807 0.024 106.324 0.030
201810 0.022 106.695 0.027
201901 0.027 106.200 0.034
201904 0.028 107.818 0.035
201909 0.019 108.329 0.023
201912 0.009 108.420 0.011
202003 0.033 108.902 0.040
202006 0.034 108.767 0.042
202009 0.040 109.815 0.048
202012 0.041 109.897 0.050
202103 0.052 111.754 0.062
202106 0.056 114.631 0.065
202109 0.055 115.734 0.063
202112 0.062 117.630 0.070
202203 0.053 121.301 0.058
202206 0.057 125.017 0.061
202209 0.059 125.227 0.063
202212 0.059 125.222 0.063
202303 0.056 127.348 0.058
202306 0.056 128.729 0.058
202309 0.048 129.860 0.049
202312 0.043 129.419 0.044
202403 0.031 131.776 0.031
202406 0.028 132.554 0.028
202409 0.025 133.029 0.025

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


4Front Ventures  (XCNQ:FFNT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


4Front Ventures Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of 4Front Ventures's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


4Front Ventures Business Description

Traded in Other Exchanges
Address
7010 E. Chauncey Lane, Suite 235, Phoenix, AZ, USA, 85054
4Front Ventures Corp is a Canadian-based company. It is engaged in the cultivation, processing, extracting, manufacturing, and distribution of cannabis products. It operates in two segments: THC Cannabis and CBD Wellness. The THC Cannabis segment engages in the production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to owned dispensaries and third-party retail customers. The CBD Wellness segment encompasses the production and sale of CBD products to third-party customers.

4Front Ventures Headlines

No Headlines